SAN DIEGO, CA - JULY 30, 2020 – Dalrada Financial Corp. (OTC Pink: DFCO) announces to its shareholders and the public that Fawad Nisar has accepted an appointment to Dalrada’s Board of Directors. Mr. Nisar’s executive leadership and vast track record in business, science, engineering, and technology further accelerates Dalrada’s global implementation strategy.
Brian Bonar, CEO of Dalrada, states, “Fawad is a proven executive leader who implements business innovation and growth. He holds an extensive background across multiple industries and has fast-tracked exponential growth within Dalrada. His Board appointment and focused guidance fuels additional worldwide growth of our portfolio of companies.”
Mr. Nisar is known for significantly improving business operations, increasing gross profit margins, expanding key client partnerships, and building efficient management teams.
With executing marketing, sales, technology, and operational efficiencies, Mr. Nisar’s executive leadership oversaw high-growth products and services for companies in healthcare, pharmaceutical, retail, engineering/product development, chemical manufacturing, and research & development.
Mr. Nisar’s degrees include an MS in Biochemical Engineering and a BS in Chemical Engineering from Manhattan College.
About Dalrada (DFCO)
Dalrada Financial Corp. (OTC Pink: DFCO) solves real-world problems by producing innovation-focused and technologically-centered solutions on a global level. Delivering next-generation manufacturing, engineering, and healthcare products and services designed to propel growth, Dalrada is a team of industry experts and an organization built upon a strong foundation of financial capital. The Company and its subsidiaries are positioned for stable long-term growth through intelligent market research, sound business acumen, and established operational infrastructure. For more information, visit www.dalrada.com or call contact firstname.lastname@example.org.
Statements in this press release that are not historical facts are forward-looking statements, including statements regarding future revenues and sales projections, plans for future financing, the ability to meet operational milestones, marketing arrangements and plans, and shipments to and regulatory approvals in international markets. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.
# # #
DALRADA FINANCIAL CORPORATION APPOINTS FAWAD NISAR TO BOARD OF DIRECTORS
July 30, 2020
EXPLORE MORE NEWS
July 20, 2020
Mr. Hershkowitz holds more than 35-years in the healthcare industry with the top Fortune 10 companies including consulting, Information Technology (IT), software, professional services, nursing schools, management, building and development.